A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients

Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

NCT02738125 ·Status: COMPLETED

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

NCT00427921 ·Status: COMPLETED ·Phase: PHASE3

Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)

NCT01346826 ·Status: COMPLETED ·Phase: PHASE4

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

NCT00195715 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice

NCT02499263 ·Status: COMPLETED

Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD

NCT06064864 ·Status: RECRUITING ·Phase: NA

Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

NCT07166588 ·Status: ENROLLING_BY_INVITATION

Post Marketing Surveillance of Remicade

NCT00724529 ·Status: COMPLETED

Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease

NCT02846961 ·Status: COMPLETED

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02499783 ·Status: COMPLETED ·Phase: PHASE3

A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

NCT05428345 ·Status: RECRUITING

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

NCT06051253 ·Status: RECRUITING ·Phase: PHASE4

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

NCT00488631 ·Status: COMPLETED ·Phase: PHASE3

Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)

NCT01960790 ·Status: COMPLETED

Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease

NCT06459297 ·Status: COMPLETED

Open-Label Adalimumab for Ulcerative Colitis Patients

NCT00421642 ·Status: COMPLETED ·Phase: PHASE1

Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

NCT07216014 ·Status: RECRUITING ·Phase: PHASE4

Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115

NCT02185014 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

NCT01848561 ·Status: ACTIVE_NOT_RECRUITING

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

NCT06095596 ·Status: RECRUITING ·Phase: NA

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

NCT02378688 ·Status: COMPLETED ·Phase: PHASE2

Vaccination Status, Knowledge and Attitude in Korean Patients With IBD

NCT01984879 ·Status: COMPLETED

Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

NCT02632175 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02015793 ·Status: COMPLETED ·Phase: PHASE2

Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease

NCT06117423 ·Status: RECRUITING ·Phase: PHASE1/PHASE2